NY 861012
APR 08 1991
CLA-2-30:S:N:N1:238 861012
Richard M. Wortman
Grunfeld, Desiderio, Lebowitz & Silverman
12 East 49th Street
New York, NY 10017
RE: The tariff classification of Serophene tablets from Israel.
Dear Mr. Wortman:
In your letter dated March 1, 1991, on behalf of Serono
Laboratories, Inc. you requested a tariff classification ruling.
The Serophene tablets contain 50mg of 2-[p-(2-chloro-1,2-
diphenylvinyl) phenoxy] triethylamine dihydrogen citrate, also
known as clomiphene citrate. It is a synthetic, non-steroidal
agent that is ingested orally and may induce ovulation.
The applicable subheading for the Serophene tablets will be
3004.90.6090, Harmonized Tariff Schedule of the United States
(HTS), which provides for medicaments (excluding goods of
heading 3002, 3005 or 3006) put up in measured doses, other,
other. The duty rate will be 6.3 percent.
Articles classifiable under subheading 3004.90.6090, HTS,
which are products of Israel are entitled to duty free treatment
under the Generalized System of Preferences (GSP) upon compliance
with all applicable regulations.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport